drugset / Trial / NCT00501527
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this trial is to evaluate the clinical effectiveness of the administration of a depigmented and polymerized allergen extract of Phleum pratense in the rhinoconjunctivitis and/or asthma of slight or moderate intensity, due to allergy to grass pollen.
Timeline
- Start
- 2007-09
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | modified extract of P. pratense pollen | Vaccine | 2 unknown | Other |